Results

Total Results: 839 records

Showing results for "phase".

441. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
     January 01, 2020 - □ Crossover studies must report at least 1 year of weight change in each phase of the crossover to … Weight loss during the intensive intervention phase of the weight-loss maintenance trial.

442. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs or … , near-death scenarios, and loss of a loved one.61,65-67 Clinical trials: Data from several late-phase

443. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
     December 31, 2017 - Interpersonal therapy generally requires 10 to 20 weekly sessions in the acute phase followed by a time-unlimited … maintenance phase.23 Group therapy refers to a general class of therapies, rather than to a specific … We will retrieve and review the full text of all titles included during the title/abstract review phase

444. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - Transferrin and ferritin are both acute-phase reactants, and in the presence of an inflammatory condition … /an, bl, me [Analysis, Blood, Metabolism] 9,955 29 *ferritins/ or *apoferritins/ 6,686 30 acute-phase

445. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase

446. Pharma-Nonpharma-Ptsd-2022-Update-App-G1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g1.xlsx
     January 01, 2022 - G-1. RoB 2 Assessment Table G-1. Risk of Bias 2 assessment of new included studies RoB Domain Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Randomization Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Allocation Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Similarit…

447. Association Between Outcomes and Dental Services in People With Substance Use Disorder: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
     May 01, 2025 - recommends only palliative and emergency treatment for patients who are not in the remission/recovery phase … - For people with SUD who are not in the remission/recovery phase, only palliative and emergency

448. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Efficacy of Immunotherapy with TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients … Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients … Di Bisceglie et al.2014 Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase … We performed a phase II open-label study to determine the efficacy, safety, and immunotherapeutic properties

449. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Efficacy of Immunotherapy with TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients … Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients … Di Bisceglie et al.2014 Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase … We performed a phase II open-label study to determine the efficacy, safety, and immunotherapeutic properties

450. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
     June 30, 2015 - We revised the phase as suggested. … program managed by Palmetto GBA is one of the gray literature sources that we explored in the early phase … Because the searches were updated during the peer review phase of the project, we have now added the … program managed by Palmetto GBA is one of the gray literature sources that we explored in the early phase

451. hemangioma-protocol-141223 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
     December 23, 2014 - exclusion criteria selected based on our understanding of the literature, input from the topic refinement phase … investigative team will also scan the reference lists of articles that are included after the full-text review phase

452. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
     May 08, 2013 - Excluded - at abstract, dual review phase, did not meet our predefined inclusion criteria. 5. … Excluded - at abstract dual review phase, did not meet our predefined inclusion criteria. 6. … Excluded - at abstract, dual review phase, did not meet our predefined inclusion criteria. 7. … Excluded - at abstract dual review phase, did not meet our predefined inclusion criteria. 9. … Excluded - at abstract dual review phase, did not meet our predefined inclusion criteria. 5.

453. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
     February 16, 2011 - /exclusion criteria we selected based on our understanding of the literature, the topic refinement phase … During the review phase of the study, the Project Coordinator will report to the Methods and Content

454. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
     June 01, 2010 - in which participants continue to be followed for a period of time after the blinded intervention phase … An important disadvantage is that participants followed during the extension phase are even more highly

455. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
     June 01, 2010 - in which participants continue to be followed for a period of time after the blinded intervention phase … An important disadvantage is that participants followed during the extension phase are even more highly

456. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
     March 29, 2011 - /exclusion criteria we selected based on our understanding of the literature, the topic-refinement phase … investigative team will also scan the reference lists of articles that are included after the full-text review phase

457. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
     February 01, 2019 - also discusses the results from each clinical workgroup, as well as the lessons learned from each phase … diesel fumes) National Quality Forum National Voluntary Consensus Standards for Patient Outcomes (Phase

458. Management of Acute Diverticulitis Topic Nomination Disposition (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/acute-diverticulitis-topic-nomination.pdf
     August 13, 2018 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase … Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.

459. Smoking-Pregnancy-Infants Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_executive.pdf
     February 01, 2014 - Two reviewers independently reviewed each publication at the full-text screening phase.

460. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
     January 01, 2018 - patients with specific diseases or risk factors, which must be clearly defined during the registry design phase … working towards accountable care determine what risk they are attempting to manage in their initial phase … Beyond best practices, this early phase of development for registries in accountable care will promote